Oncology · Phase III

Top sponsors

• AstraZeneca 75 programs
• Chinese Academy of 70 programs
• HOFFMANN-LA ROCHE 68 programs
• MSD Merck Sharp 56 programs
• First People's Hospital 53 programs
• Ningbo Cancer Hospital 44 programs
• United Therapeutics Europe 43 programs
• Anaxis Pharma 37 programs
• AstraZeneca 37 programs
• Novartis India 32 programs
• George Institute for 29 programs
• Takeda 28 programs

1. HCB-ONC002

   The George Institute

   HER2-positive early breast cancer

   phase 3 · small molecule · active

   1 trial →

2. HD201

   Prestige Biopharma Belgium

   HER2 Positive Breast Cancer

   phase 3 · small molecule · completed

   1 trial →

3. HIPEC with neoadjuvant chemotherapy

   Xiyuan Hospital of China Academy of Chinese Medical Sciences

   Gastric Cancer

   phase 3 · other · active

   1 trial →

4. HLX02

   Shanghai Henlius Biotech

   Breast Cancer

   phase 3 · mab · completed

   1 trial →

5. HOVON 127 BL

   Wuhan Createrna Science and Technology Co., Ltd

   Burkitt lymphoma

   phase 3 · small molecule · active

   1 trial →

6. HQP1351AG301

   Lacuna Pharma Pty Ltd

   Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

   phase 3 · small molecule · active

   1 trial →

7. HQP1351CG301

   Lacuna Pharma Pty Ltd

   Chronic Phase Chronic Myeloid Leukemia

   phase 3 · small molecule · active

   1 trial →

8. HS-19-657

   Camurus Pty Ltd

   gastroenteropancreatic neuroendocrine tumors

   phase 3 · small molecule · active

   1 trial →

9. HVA

   The First People's Hospital of Lianyungang

   Newly Diagnosed Acute Myeloid Leukemia With High Risk

   phase 3 · small molecule · active

   1 trial →

10. Herceptin

    Hoffmann-La Roche

    Breast Neoplasms

    phase 3 · small molecule · completed

    1 trial →

11. Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

    The First People's Hospital of Lianyungang

    Gastric Cancer

    phase 3 · other · active

    1 trial →

12. I3Y-MC-JPCF

    Eli Lilly Co.

    Breast Cancer

    phase 3 · small molecule · active

    1 trial →

13. I3Y-MC-JPCM

    Eli Lilly Co.

    Prostate Cancer

    phase 3 · small molecule · active

    1 trial →

14. I3Y-MC-JPEF

    Eli Lilly Co.

    Breast Neoplasm, Neoplasm Metastasis

    phase 3 · small molecule · active

    1 trial →

15. IAC regimen

    The First People's Hospital of Lianyungang

    Acute Myeloid Leukemia

    phase 3 · small molecule · completed

    1 trial →

16. IB2017-04

    The George Institute

    Resectable, non-metastatic soft-tissue sarcoma (STS)

    phase 3 · small molecule · active

    1 trial →

17. IBCSG 59-19

    Partner Therapeutics Limited

    Female or male patients with histologically confirmed HR-positive, HER2-negative resected isolated locoregional recurrence (ILRR) of breast cancer.

    phase 3 · small molecule · active

    1 trial →

18. ICM ADX-2191 injection

    Aldeyra Therapeutics

    Primary Vitreoretinal Lymphoma

    phase 3 · small molecule · active

    1 trial →

19. IDE196

    IDEAYA Biosciences

    Metastatic Uveal Melanoma

    phase 3 · small molecule · active

    2 trials →

20. IDE196 (LXS196), IDE196 (LXS196)

    IDEAYA Biosciences

    Uveal Melanoma

    phase 3 · small molecule · active

    1 trial →

21. IDE196-002

    IDEAYA Biosciences

    HLA-A2 negative metastatic uveal melanoma

    phase 3 · small molecule · active

    1 trial →

22. IDE196-002

    IDEAYA Biosciences

    HLA-A2 negative metastatic uveal melanoma

    phase 3 · small molecule · active

    1 trial →

23. IFCT-1701

    CERO THERAPEUTICS HOLDINGS, INC.

    Non small cell lung cancer

    phase 3 · small molecule · active

    1 trial →

24. IFCT-1805

    CERO THERAPEUTICS HOLDINGS, INC.

    Non Small Cell Lung Cancer

    phase 3 · small molecule · active

    1 trial →

25. IFCT-2103

    CERO THERAPEUTICS HOLDINGS, INC.

    Non small cell lung cancer

    phase 3 · small molecule · active

    1 trial →

26. IFOM-CPT0092022PO008

    Fondazione Telethon ETS

    Colon cancer

    phase 3 · small molecule · active

    1 trial →

27. IFx-Hu2.0

    TuHURA Biosciences, Inc./NV

    Advanced Or Metastatic Merkel Cell Carcinoma

    phase 3 · small molecule · active

    2 trials →

28. IJB-SHAPERS-ODN-013

    The George Institute

    locally advanced rectal cancer

    phase 3 · small molecule · active

    1 trial →

29. IM JZP-458

    Jazz Pharmaceuticals Ireland Limited

    Acute Lymphoblastic Leukemia

    phase 3 · small molecule · completed

    1 trial →

30. IMFINZI 50 mg/mL concentrate for solution for infusion.

    Wuhan Createrna Science and Technology Co., Ltd

    Small-cell lung cancer, extensive stage

    phase 3 · small molecule · active

    1 trial →

31. IMFINZI 50 mg/mL concentrate for solution for infusion.

    AstraZeneca

    small cell lung cancer

    phase 3 · small molecule · active

    1 trial →

32. IMFINZI for Advanced Biliary Cancer (ABC)

    Ningbo Cancer Hospital

    Advanced Biliary Cancer (ABC)

    phase 3 · small molecule · active

    1 trial →

33. IMMU-132-13

    Gilead Sciences Pty Limited

    Locally Advanced or Metastatic Unresectable Urothelial Cancer

    phase 3 · small molecule · active

    1 trial →

34. INBRX-106

    Inhibrx Biosciences

    Head and Neck Squamous Cell Carcinoma (HNSCC)

    phase 3 · small molecule · active

    1 trial →

35. INBRX106-01-201

    Inhibrx Biosciences

    Head and Neck Squamous Cell Carcinoma

    phase 3 · small molecule · active

    1 trial →

36. INCA033890-303

    Incyte

    Metastatic Microsatellite Stable Colorectal Cancer

    phase 3 · small molecule · active

    1 trial →

37. INCB 54828-302

    Incyte

    Cholangiocarcinoma

    phase 3 · small molecule · active

    1 trial →

38. INCB123667-305

    Incyte

    Ovarian cancer

    phase 3 · small molecule · active

    1 trial →

39. INCMGA 0012-304

    Incyte

    Metastatic nonsquamous or squamous non-small cell lung cancer

    phase 3 · small molecule · active

    1 trial →

40. INCMOR 0208-305

    Incyte

    Diffuse large B-cell lymphoma (DLBCL)

    phase 3 · small molecule · active

    1 trial →

41. INCMOR0208-301

    Incyte

    follicular lymphoma (FL) and marginal zone lymphoma (MZL)

    phase 3 · small molecule · active

    1 trial →

42. INFLUENCE

    AXIM BIOTECHNOLOGIES, INC.

    B-cell Acute Lymphoblastic Leukemia

    phase 3 · small molecule · active

    1 trial →

43. INT230-6

    INTENSITY THERAPEUTICS, INC.

    Sarcoma,Soft Tissue

    phase 3 · small molecule · active

    1 trial →

44. IO102-IO103

    IO Biotech

    Metastatic Melanoma

    phase 3 · small molecule · active

    1 trial →

45. IOB-013/KN-D18

    IO Biotech

    Previously untreated, unresectable, or metastatic melanoma

    phase 3 · small molecule · active

    1 trial →

46. ION363-CS1

    IONIS PHARMACEUTICALS INC

    Amyotrophic Lateral Sclerosis with Fused in Sarcoma mutations

    phase 3 · small molecule · active

    1 trial →

47. IOV-MEL-301

    Iovance Biotherapeutics B.V.

    Melanoma

    phase 3 · small molecule · active

    1 trial →

48. IP

    Solid Biosciences

    Small Cell Lung Cancer

    phase 3 · small molecule · completed

    1 trial →

Frequently asked questions